IL17A and inflammatory bowel disease: Considering increased expression of IL-17 has been observed in the intestinal mucosa of patients with IBD, IL-17 may facilitate the progression of IBD, which is mainly related to intestinal mucosal immune response, for using neutralizing antibody, IBD symptoms were effectively relieved.